ArticleFrontiers in cell and developmental biology2026
Tissue-specific oxidative stress and bleomycin hydrolase signatures are associated with organ-specific fibrotic responses in a mouse model of systemic sclerosis.
Article in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Systemic sclerosis (SSc) is a multisystem autoimmune disease characterized by inflammation, vasculopathy, and progressive fibrosis, yet the mechanisms underlying specific organ involvement are incompletely understood. Using the bleomycin-osmotic minipump (BLM-MP) mouse model, which recapitulates key clinical and histopathological features of SSc, we investigated whether tissue-specific oxidative stress responses and BLM metabolism are associated with divergent inflammatory and fibrotic remodeling across organs. Male C57BL/6 mice received continuous systemic infusion of BLM or saline for 7 days. Lungs, skin, kidneys, and liver were analyzed 14 and 28 days later by histopathology, collagen quantification, immunohistochemistry, and RT-qPCR. Systemic BLM exposure induced distinct organ-specific inflammatory, fibrotic and molecular responses. Progressive fibrosis and inflammatory infiltration developed predominantly in the lungs and skin, whereas the kidneys exhibited only mild focal cortical fibrosis and the liver remained largely unaffected. Fibrosis-prone organs displayed impaired antioxidant responses, characterized by reduced expression of superoxide dismutase 1 (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.